Yang Song

Yang Song

Auto-generated profile, based on publicly available information

Yang Song

Laboratory Animal Center, Changzhi Medical College, Changzhi 046000, P. R. China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Cancer Research
Verified
Journal Article
Closed access
JZJing Zhang
Jing Zhang
HZHushan Zhang
Hushan Zhang
FLFeng Ling
Feng Ling
YWYuanhan Wang
Yuanhan Wang
LLLong Li
Long Li
SYSong Yang
Song Yang
Background: As the more malignant subtype of lung cancer, small cell lung cancer (SCLC) displayed more aggressive and worse prognosis. Standard treatments have rarely changed in decades, therefore, in recent years, there have been attempts to explore targeted therapy and even immunotherapy. However, SCLC has more challenging targets. It was reported that almost 100% of SCLC has p53 and Rb mutations, and also has functional changes in Myc. Here we report some data about gene mutation of SCLC of Chinese patients. Methods: Tumor samples of 410 SCLC patients were consecutively collected in China from July 2018 to May 2020, next generation sequencing (NGS) was performed to detect gene mutation, and tumor mutational burden (TMB) measured by a 733 gene panel. PD-L1 expression detected by using Dako PD-L1 IHC 22C3 pharmDx, Tumor Proportion Score (TPS) was used to determine expression of PD-L1. TPS was arranged into the following intervals: strong positive ≥50%, moderate positive ≥5% and <50%, weak positive ≥1% and <5%, and negative <1%. All these were performed by 3D Medicines, a laboratory accredited by College of American Pathologists (CAP) and Clinical Laboratory Improvement Amendments (CLIA). Results: NGS results showed that the top gene mutation in these 410 Chinese SCLC patients were TP53 (88.0%,361/410), RB1(63.9%,262/410), BRCA1/2(34.0%,139/410), LRP1B(28.3%,116/410), FAM135B(24.1%,99/410), PIK3CA(23.9%,98/410), CYP2D6(21.0%,86/410), POLA1(20.2%,83/410), NTRK1(19.5%,80/410), MSH2(19.3%,79/410), ATM(19.3%,79/410), AKT2(18.8%,77/410), VEGFA(18.8%,77/410). Furthermore, 159 samples available for TMB analysis, and results showed that the average TMB level was 11.7 mutants/Mb, and 49.7%(79/159) were higher than 10 mutants/Mb, and 50.3%(80/159) were under 10mutants/Mb. In addition, 167 samples available for PD-L1 analysis, and results showed that 86.8% (145/167) with PD-L1 negative, 7.8(13/167) moderate positive, none with PD-L1 strong positive. Conclusion: Chinese patients with SCLC have rich spectrum of gene mutations, it suggests that targeted therapy should also have certain potential. In addition, about half of SCLCs have a TMB level above 10mutants/Mb, and immunotherapy should been considered more in the future treatment for Chinese SCLC patients. Citation Format: Jing Zhang, Hushan Zhang, Feng Ling, Yuanhan Wang, Long Li, Song Yang. Analysis of gene landscape of small cell lung cancer of Chinese through next-generation sequencing [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2021; 2021 Apr 10-15 and May 17-21. Philadelphia (PA): AACR; Cancer Res 2021;81(13_Suppl):Abstract nr 2219.

1 January 2024 in Analytical Cellular Pathology
Verified
Journal Article
Open access
HZHuiPeng Zhang
HuiPeng Zhang
ZQZhongyu Qin
Zhongyu Qin
SSShuaiShuai Shi
ShuaiShuai Shi
YLYunFei Li
YunFei Li
YSYang Song
Yang Song
YZyiqinag zhang
yiqinag zhang
This study aimed to construct an eukaryotic expression vector, pEGFP‐N1‐MIC‐1, for overexpressing the mouse macrophage inhibitory cytokine‐1 (MIC‐1) gene. Additionally, we transfected the MFC cell line to observe the upregulation of MIC‐1 gene expression and assess its impact on macrophage phenotype conversion. Enzyme digestion and DNA sequencing confirmed the successful construction of the pEGFP‐N1‐MIC‐1 vector. The transfected MFC cells exhibited a significant increase in MIC‐1 protein expression levels. Furthermore, transfection with pEGFP‐N1‐MIC‐1 increased the migration and colony formation capabilities of MFC cells. These results may contribute to future research and the development of therapeutic interventions targeting MIC‐1 in macrophages, particularly in the context of gastric cancer.

28 February 2026 in Nano
Verified
Journal Article
Closed access
YSYang Song
Yang Song
JBJianliang Bai
Jianliang Bai
PNPengyan Niu
Pengyan Niu
KGKexin Geng
Kexin Geng
ZZZhinan Zhan
Zhinan Zhan
RPRunfang Pei
Runfang Pei